Albireo Pharma General and Administrative Expenses 2011-2026 | ALBO

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses Albireo Pharma

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
69.6 M	42.4 M	23 M	18.1 M	15.2 M	10.3 M	6.4 M	5.6 M	6.84 M	6.82 M	9.32 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
69.6 M	5.6 M	19.4 M

Quarterly General and Administrative Expenses Albireo Pharma

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	20.6 M	21.6 M	16.9 M	-	17.6 M	16.9 M	15.3 M	-	11.7 M	8.47 M	8.15 M	-	6.01 M	5.48 M	5.29 M	-	3.85 M	4.24 M	4.13 M	-	3.71 M	3.71 M	3.21 M	-	1.35 M	3.03 M	1.31 M	1.63 M	4.97 M	1.52 M	1.61 M	1.83 M	4.48 M	1.35 M	1.83 M	1.4 M	5.37 M	1.77 M	1.4 M	1.43 M	5.63 M	1.78 M	1.37 M	2.02 M	7.26 M	2.38 M	2.02 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
21.6 M	1.31 M	5.74 M

General and Administrative Expenses of other stocks in the Biotechnology industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	78.3 M	-	2.43 %	$ 254 M	Germany
Alector ALEC	54 M	$ 2.11	-13.17 %	$ 217 M	USA
Acer Therapeutics ACER	12.7 M	-	2.71 %	$ 14 M	USA
Axsome Therapeutics AXSM	63.3 M	$ 163.89	-	$ 8.15 B	USA
BridgeBio Pharma BBIO	531 M	$ 64.28	-3.31 %	$ 12.3 B	USA
I-Mab IMAB	900 M	-	-	$ 866 M	China
BioCardia BCDA	4.4 M	$ 1.37	5.81 %	$ 29 M	USA
Alexion Pharmaceuticals, Inc. ALXN	1.4 B	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	9.33 M	-	-10.17 %	$ 12.2 K	USA
Biophytis SA BPTS	7.15 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	47.9 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	17 M	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	4.66 M	-	-1.52 %	$ 24.7 M	USA
BioLineRx Ltd. BLRX	4.31 M	$ 2.82	-0.35 %	$ 908 M	Israel
Midatech Pharma plc MTP	4.95 M	-	-18.52 %	$ 27.3 M	Britain
BioMarin Pharmaceutical BMRN	1.15 B	$ 59.8	-3.13 %	$ 11.5 B	USA
Bristol-Myers Squibb Company BMY	7.27 B	$ 62.08	-0.46 %	$ 126 B	USA
Benitec Biopharma BNTC	6.97 M	$ 10.93	0.23 %	$ 450 M	USA
BioNTech SE BNTX	286 M	$ 109.33	-0.82 %	$ 27.2 B	Germany
Black Diamond Therapeutics BDTX	27.5 M	$ 2.38	-3.44 %	$ 131 M	USA
ARCA biopharma ABIO	13.1 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	89.7 M	-	-24.86 %	$ 820 K	USA
BioXcel Therapeutics BTAI	34.5 M	$ 1.63	-2.4 %	$ 4.13 M	USA
Acasti Pharma ACST	7.17 M	-	4.01 %	$ 150 M	Canada
Burford Capital Limited BUR	99.3 M	$ 8.65	2.49 %	$ 1.39 B	Britain
Adverum Biotechnologies ADVM	63.1 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	25.8 M	-	-	-	Russia
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	37.9 M	-	-	$ 3.67 B	USA
Akouos AKUS	22.2 M	-	0.23 %	$ 488 M	USA
BeyondSpring BYSI	30.7 M	$ 1.34	-0.87 %	$ 54 M	USA
Allena Pharmaceuticals ALNA	12.7 M	-	3.16 %	$ 1.9 M	USA
Cabaletta Bio CABA	19.2 M	$ 3.34	0.61 %	$ 3.9 M	USA
Aileron Therapeutics ALRN	13.9 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	42.9 M	-	4.14 %	$ 49.1 M	USA
Can-Fite BioPharma Ltd. CANF	3.05 M	$ 4.88	2.74 %	$ 10.6 B	Israel
Alpine Immune Sciences ALPN	18 M	-	-	$ 2.17 B	USA
Capricor Therapeutics CAPR	12.8 M	$ 27.28	-2.32 %	$ 731 M	USA
Aeterna Zentaris AEZS	5.92 M	-	5.93 %	$ 314 M	Canada
Ampio Pharmaceuticals AMPE	7.08 M	-	-11.43 %	$ 502 K	USA
Catalyst Biosciences CBIO	14.7 M	$ 11.67	-3.47 %	$ 768 M	USA
Applied Molecular Transport AMTI	37.4 M	-	-	$ 10.1 M	USA
Aravive ARAV	13 M	-	-13.39 %	$ 1.45 M	USA
C4 Therapeutics CCCC	36.2 M	$ 3.06	13.3 %	$ 254 M	USA
Aptose Biosciences APTO	11.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	19.8 M	-	-39.0 %	$ 4.57 M	USA
Athira Pharma ATHA	26.1 M	-	-	$ 269 M	USA
Codexis CDXS	55.1 M	$ 0.99	-2.04 %	$ 72.7 M	USA
Aridis Pharmaceuticals ARDS	7.16 M	-	17.91 %	$ 11.1 M	USA